A XM não fornece serviços a residentes nos Estados Unidos da América.

S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-S&P 500 ends up, win streak at 5; Nasdaq ekes out gain even as Alphabet weighs</title></head><body>

S&P 500, Nasdaq extend win streaks to five

U.S. CPI rises as expected in July

Alphabet dips after report US mulls Google break-up

VIX records fastest ever drop from high-fear range

Indexes up: Dow 0.61%, S&P 500 0.38%, Nasdaq 0.03%

Adds closing prices

By David French

Aug 14 (Reuters) -The S&P 500 ended higheron Wednesday, stretching its winning streak to five sessions, as the latest inflation data reassured investors betting the Federal Reserve would start cutting U.S. interest rates next month.

The Nasdaq Composite also posted its fifth straight daily gain, although it barely scraped into positive territory asAlphabet and some megacap tech stocks weighed.

Moves were generally subdued with many investors away for August vacations, and new triggers for trading were absent, contributing to an overall listless picture among the benchmarks.

The latest U.S. consumer price data, released earlier on Wednesday, reinforced expectations that the Fed would start interest rate cuts inSeptember.

U.S. consumer prices rose moderately in July, and the annual increase in inflation slowed to below 3% for the first time since early 2021. A day earlier,softer-than-expected producer prices data indicated inflation continued to moderate, although not yet all the way to the U.S. central bank's 2% target.

Money markets now see a 55% chance of a 25-basis point (bps) rate cut at the Fed's Sept. 17-18 meeting, as per the CME FedWatch Tool. Before the data, traders were nearly evenly split between a 25-bps and 50-bps cut.

Scott Ladner, chief investment officer at Horizon Investments, said he called days such as this "markets violently going nowhere", adding with CPI painting a similar picture to PPI data, there was no reason for traders to reassess moves put in place on the previous day.

"There's no huge rationale to move prices one way or another," he said.

The S&P 500 .SPX closed at 5,455.21, up 0.38% or 20.78 points. The Nasdaq Composite .IXICclosed at 17,192.60, up 0.03% or 4.99 points. The Dow Jones Industrial Average .DJI closed up 242.75 points or 0.61% at 40,008.39.

Shares of Alphabet, the Google-parent GOOGL.O, dropped 2.3% on a media report that the U.S. Department of Justice is considering options that include breaking up the online search engine.

Other megacaps were mixed: Tesla TSLA.O slumped 3.1% andMeta Platforms dropped 0.3%, while Microsoft MSFT.O fell 0.7% andNvidia NVDA.O declined 1.7%.

A rebound in megacap and tech stocks has helped markets recoup most losses from a global market rout early this month after data showed the U.S. unemployment rate surged in July.

Thursday's release by the Commerce Department's Census Bureau of retail sales data will be keenly watched by those concerned about the overall strength of the American economy, Horizon's Ladner said.

These worries had sent the Cboe volatility index .VIX, Wall Street's fear gauge, to its highest since 2020 just last week. However, on Wednesday, it stayed below its long term average of 20 points for the second day to close at16.19.

The seven trading sessions it took the VIX to return to its long-term median of 17.6 is the index’s quickest ever drop from 35, a level associated with a high degree of fear, according to aReuters analysis.

A majority of the major S&P sectors were in positive territory, led by a 1.3% risein financials .SPSY. Its advance was aided by gains of more than 4.6% by Progressive PGR.N and Charles Schwab SCHW.N, which rose after positive July performance numbers, and Allstate ALL.N, which climbed after agreeing to sell a business unit.

Both of the insurers ended at record closing highs.

Kellanova K.N surged 7.8% afterfamily-owned candy giant Mars said it would buy the Cheez-It and Pringles maker in a nearly $36 billion deal.

Cardinal Health CAH.N gained 3.7% after the drug distributor raised its 2025 profit forecast.



Reporting by Medha Singh and Shashwat Chauhan in Bengaluru and David French in New York; Editing by Maju Samuel and David Gregorio

</body></html>

Isenção de Responsabilidade: As entidades do XM Group proporcionam serviço de apenas-execução e acesso à nossa plataforma online de negociação, permitindo a visualização e/ou uso do conteúdo disponível no website ou através deste, o que não se destina a alterar ou a expandir o supracitado. Tal acesso e uso estão sempre sujeitos a: (i) Termos e Condições; (ii) Avisos de Risco; e (iii) Termos de Responsabilidade. Este, é desta forma, fornecido como informação generalizada. Particularmente, por favor esteja ciente que os conteúdos da nossa plataforma online de negociação não constituem solicitação ou oferta para iniciar qualquer transação nos mercados financeiros. Negociar em qualquer mercado financeiro envolve um nível de risco significativo de perda do capital.

Todo o material publicado na nossa plataforma de negociação online tem apenas objetivos educacionais/informativos e não contém — e não deve ser considerado conter — conselhos e recomendações financeiras, de negociação ou fiscalidade de investimentos, registo de preços de negociação, oferta e solicitação de transação em qualquer instrumento financeiro ou promoção financeira não solicitada direcionadas a si.

Qual conteúdo obtido por uma terceira parte, assim como o conteúdo preparado pela XM, tais como, opiniões, pesquisa, análises, preços, outra informação ou links para websites de terceiras partes contidos neste website são prestados "no estado em que se encontram", como um comentário de mercado generalizado e não constitui conselho de investimento. Na medida em que qualquer conteúdo é construído como pesquisa de investimento, deve considerar e aceitar que este não tem como objetivo e nem foi preparado de acordo com os requisitos legais concebidos para promover a independência da pesquisa de investimento, desta forma, deve ser considerado material de marketing sob as leis e regulações relevantes. Por favor, certifique-se que leu e compreendeu a nossa Notificação sobre Pesquisa de Investimento não-independente e o Aviso de Risco, relativos à informação supracitada, os quais podem ser acedidos aqui.

Aviso de risco: O seu capital está em risco. Os produtos alavancados podem não ser adequados para todos. Recomendamos que consulte a nossa Divulgação de Riscos.